Navigating the ASE 2023 Guideline Updates Without Losing Your Mind

The latest round of updates from the American Society Of Echocardiography 2023 landed on my desk about three months ago, and honestly, the sheer volume of revised recommendations is enough to make any sonographer or cardiologist just close the PDF and go back to what they already know. But you can't afford to ignore it. A lot of the changes are subtle enough that they won't jump out at you during a casual read-through, and that's exactly where things get dangerous.

What Actually Changed in American Society Of Echocardiography 2023

The main document most people are talking about is the update on valve disease assessment, specifically around aortic stenosis severity grading. They shifted some of the threshold values for defining severe disease based on newer outcome data. The old benchmarks you memorized in fellowship are now slightly different, and if you're still using the previous cutoffs in your reports, you're either overcalling or undercalling severity depending on which patient you're looking at. There's also an updated recommendation on left ventricular ejection fraction reporting. They've moved away from the simple visual estimate as a standalone method and are pushing for a more structured approach that incorporates strain imaging when available. This isn't just academic preference — the data shows that visual estimation alone has a wide margin of error, especially in patients with baseline wall motion abnormalities or post-intervention hearts. I ran into a concrete problem last month with a 72-year-old female who had undergone TAVR six weeks prior. Her follow-up echo was straightforward on the surface, but when I tried to grade her residual aortic stenosis using the older ASE criteria, the numbers looked borderline. Severe by old standards. Mild by the new ones. The difference between those two calls changes the entire management pathway. What I ended up doing was pulling the continuity equation data, running the valve area calculation three separate times across different cardiac cycles, and cross-referencing it with the peak velocity profile across the full systolic ejection period. The velocity time integral ratio came back consistent with mild residual gradient. That became my final call. It took me about 20 minutes longer than a routine report, but it was the right call.

The Counter-Intuitive Parts Beginners Miss

One thing the guidelines don't emphasize enough is that the new ejection fraction methodology actually requires *more* image acquisition time, not less. There's a misconception floating around that adopting the updated framework means you can scan faster. It doesn't. You need cleaner apical views, standardized clip lengths, and consistent tracking windows. In practice, this adds maybe three to five minutes to a standard transthoracic exam. If your lab is running tight schedules and your technologists aren't comfortable with the new framing requirements, the strain data quality will suffer, and then you've lost both the efficiency gain and the accuracy improvement. Another blind spot: the guidelines talk extensively about when to use which measurement technique, but they're relatively quiet about what to do when the techniques disagree. I've seen this constantly with mitral regurgitation assessment. The 2023 update tightened the criteria for proximal isovelocity surface area (PISA) measurements, which is good, but PISA and vena contracta will still give you different answers in about 15 to 20 percent of cases in my experience. When they diverge, the guideline algorithm says to go with the multimodality approach, which basically means defaulting to the method you're most confident in and documenting the discrepancy. It's not a satisfying answer, but it's the honest one.

Practical Steps for Implementation

If you're looking at integrating this into your workflow, start with the aortic stenosis section. That's where the clinical impact is largest and the changes are most actionable. Pull up the current ASE algorithm for AS severity classification and compare it side by side with the 2019 version. The differences are there but easy to gloss over. Highlight them. Print them out. Tape them to your monitor if you have to. For the Ejection fraction changes, the practical move is to spend a week re-acquiring your standard apical views with an eye toward later strain analysis. You'll notice which images are usable and which aren't before you even try to run the post-processing. Most labs lose about a third of their potential strain data on first pass because the initial acquisition wasn't clean enough. That's not a software problem, it's an acquisition problem. You can find the full guidelines on the ASE website. They're behind a member paywall for the complete documents, but the summary recommendations are freely accessible. If your institution doesn't have a subscription, check with your department director — most hospitals already have one and it's worth leveraging it rather than trying to piece it together from free summaries. The biggest practical tip I can offer is that these updates are incremental, not revolutionary. Don't treat them like a complete rewrite. They represent a refinement of existing frameworks, and the best approach is to adopt them selectively where they change your clinical decisions rather than overhauling your entire protocol overnight. You'll catch fewer edge cases that way, and your colleagues will notice less friction in the reading room.